Evaluation of Glycemic Control Among Type 2 Diabetic Patients in the First Visit After COVID-19 Lockdown, Prince Mansour Military Hospital, Taif, Saudi Arabia

Overview

Journal J Family Med Prim Care

Specialty Public Health

Date 2023 Jan 9

PMID 36618131

Authors

Jumanah A Alsaedi

Abdulaziz F Alfadhly

Affiliations

Soon will be listed here.

Abstract

Background: The coronavirus disease (COVID-19) pandemic causes significant morbidities and mortalities. Lockdown is applied worldwide to counteract the spread of the disease. These circumstances limit diabetic patients from hospital visits and follow-ups.

Objectives: To evaluate glycemic control for type 2 diabetic patients in the first visit after COVID-19 lockdown and to study the effect of COVID-19 lockdown on glycemic control.

Methods: A cross-sectional study was conducted at Prince Mansour Military Hospital, Taif city, Western Saudi Arabia. It included type 2 diabetic patients of both genders aged over 20 years that were assigned to follow-up in the diabetic center. Data were collected from patients' medical records using a simple random technique. It included patients` gender, age group, body mass index, and three glycosylated hemoglobin (HbA1c) readings for each year (2018-2019) and one HbA1C reading upon the first visit after COVID-19 lockdown. HbA1c level was treated as a continuous variable.

Results: The study included 420 diabetic patients. Females represented 51% of them, and more than a third (39.8%) were aged 60 years and over. The majority of them were either overweight (29.3%) or obese (61.2%). There was an increase in the overall level of HbA1c after curfew (8.72 ± 1.73) than before it (8.58 ± 1.72). However, the difference did not reach a statistically significant level, = 0.056. Among females, the level of hemoglobin A1c (HbA1c) was statistically and significantly higher after curfew than before it (8.71 ± 1.82 vs. 8.43 ± 1.71), = 0.005. Also, among obese subjects, the level of hemoglobin A1c was statistically and significantly higher after curfew than before it (8.55 ± 1.74 vs. 8.34 ± 1.63), = 0.034.

Conclusion: There was a relative increase in the level of HbA1c after the lockdown during COVID-19, indicating poorer glycemic control; this impact was more obvious among female and obese type 2 diabetic patients.

References

Hosomi Y, Munekawa C, Hashimoto Y, Okamura T, Takahashi F, Kawano R . The effect of COVID-19 pandemic on the lifestyle and glycemic control in patients with type 1 diabetes: a retrospective cohort study. Diabetol Int. 2021; 13(1):85-90. PMC: 8054854. DOI: 10.1007/s13340-021-00507-4. View

Tadic M, Cuspidi C, Sala C . COVID-19 and diabetes: Is there enough evidence?. J Clin Hypertens (Greenwich). 2020; 22(6):943-948. PMC: 7300807. DOI: 10.1111/jch.13912. View

Al Agha A, Alharbi R, Almohammadi O, Yousef S, Sulimani A, Alaama R . Impact of COVID-19 lockdown on glycemic control in children and adolescents. Saudi Med J. 2021; 42(1):44-48. PMC: 7989327. DOI: 10.15537/smj.2021.1.25620. View

Tan S, Mei Wong J, Sim Y, Wong S, Elhassan S, Tan S . Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention. Diabetes Metab Syndr. 2019; 13(1):364-372. DOI: 10.1016/j.dsx.2018.10.008. View

Eberle C, Stichling S . Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review. Diabetol Metab Syndr. 2021; 13(1):95. PMC: 8423337. DOI: 10.1186/s13098-021-00705-9. View

Ghosal S, Sinha B, Majumder M, Misra A . Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis. Diabetes Metab Syndr. 2020; 14(4):319-323. PMC: 7146694. DOI: 10.1016/j.dsx.2020.03.014. View

Beato-Vibora P . RETRACTED: No deleterious effect of lockdown due to COVID-19 pandemic on glycaemic control, measured by glucose monitoring, in adults with type 1 diabetes. Diabetes Technol Ther. 2020; . DOI: 10.1089/dia.2020.0184. View

Ghosh A, Arora B, Gupta R, Anoop S, Misra A . Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India. Diabetes Metab Syndr. 2020; 14(5):917-920. PMC: 7265851. DOI: 10.1016/j.dsx.2020.05.044. View

Lippi G, Henry B, Bovo C, Sanchis-Gomar F . Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19). Diagnosis (Berl). 2020; 7(2):85-90. DOI: 10.1515/dx-2020-0041. View

10.

Alshareef R, Al Zahrani A, Alzahrani A, Ghandoura L . Impact of the COVID-19 lockdown on diabetes patients in Jeddah, Saudi Arabia. Diabetes Metab Syndr. 2020; 14(5):1583-1587. PMC: 7422800. DOI: 10.1016/j.dsx.2020.07.051. View

11.

Zhu L, She Z, Cheng X, Qin J, Zhang X, Cai J . Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020; 31(6):1068-1077.e3. PMC: 7252168. DOI: 10.1016/j.cmet.2020.04.021. View

12.

Bonora B, Boscari F, Avogaro A, Bruttomesso D, Fadini G . Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy. Diabetes Ther. 2020; 11(6):1369-1379. PMC: 7213551. DOI: 10.1007/s13300-020-00829-7. View

13.

Muniyappa R, Gubbi S . COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Endocrinol Metab. 2020; 318(5):E736-E741. PMC: 7191633. DOI: 10.1152/ajpendo.00124.2020. View

14.

Cuschieri S, Grech S . COVID-19 and diabetes: The why, the what and the how. J Diabetes Complications. 2020; 34(9):107637. PMC: 7242955. DOI: 10.1016/j.jdiacomp.2020.107637. View

15.

Bloomgarden Z . Diabetes and COVID-19. J Diabetes. 2020; 12(4):347-348. DOI: 10.1111/1753-0407.13027. View

16.

Ruiz-Roso M, Knott-Torcal C, Matilla-Escalante D, Garcimartin A, Sampedro-Nunez M, Davalos A . COVID-19 Lockdown and Changes of the Dietary Pattern and Physical Activity Habits in a Cohort of Patients with Type 2 Diabetes Mellitus. Nutrients. 2020; 12(8). PMC: 7468739. DOI: 10.3390/nu12082327. View

17.

Kowall B, Kostev K, Landgraf R, Hauner H, Bierwirth R, Rathmann W . Effects of the COVID-19 lockdown on primary health care for persons with type 2 diabetes - Results from the German Disease Analyzer database. Diabetes Res Clin Pract. 2021; 179:109002. DOI: 10.1016/j.diabres.2021.109002. View